Gene regulatory networks and Gene expression Data |
1 |
DTI prediction for repositioning [113]
|
Network propagation, scoring based on neighborhood, random walks |
GEO repository for Gene expression data |
AUC - ROC |
2 |
A network flow approach for repurposing with case study on prostate cancer [115]
|
Maximum Flow |
OMIM, KEGG, PGDB, DrugBank |
Precision, Mean, Position |
3 |
NFFinder [119]
|
Statistical method for analysis |
Cmap, DrugMatrix, and GEO |
– |
4 |
System biology approach developed by a novel knowledge-driven method [121]
|
Bayesian network-based approach |
Gene-gene interaction |
– |
5 |
Functional Module Method with case study of Prostate Cancer [145]
|
Functional linkage network |
TCGA, LINCS, GEO, OMIM |
AUC - ROC |
6 |
computational DR using Kolmogorov– Smirnov enrichment testing for [123]
|
Enrichment (Kolmogorov–Smirnov) |
GEO and CTD |
– |
Protein–protein interaction networks |
7 |
Network Analysis for potential DTI identification [146]
|
SVM, Logistic regression, L1-regularization, KNN |
STRING, DrugBank, Gene cards |
Z score and Standard deviation |
8 |
Comprehension of Complex disease using PPIN [112]
|
– |
Gene expression omnibus (GEO) |
Harmonic mean and Precision |
9 |
Drug repurposing shared network of PPIs and genes [147]
|
Similarity |
STRING and DrugBank |
– |
10 |
PPINs and MMP cellular model [148]
|
Cross talk by analysis of betweenness centrality |
KEGG, OMIM and iRef Index database |
– |
Drug–target interactions |
11 |
DTI prediction using Probabilistic soft logic [135]
|
Soft probabilistic logic |
DrugBank, KEGG, DCDB, and Matador |
AUC, Precision, AUPR |
12 |
Network-based inference for prediction of DTI [136]
|
– |
DrugBank |
AUC and Precision |
13 |
Bayesian matrix factorization-based DTI prediction[111]
|
Prediction based on Bayesian algorithm |
DrugBank and DTIs |
AUC |
14 |
DTI prediction from integration of chemical and genomic spaces [138]
|
Bi-partite graph ML |
DrugBank and DTIs |
AUC |
15 |
Bipartite model for DTI prediction [139]
|
Supervised method of network inference |
DrugBank and DTIs |
AUC-ROC, AUPR |
Drug–disease and side-effect association |
16 |
Drug repositioning methods based on network inference [149]
|
– |
CTD |
AUC-ROC |
17 |
PREDICT, a method to infer the new indications [44]
|
Logistic regression |
DrugBank, SIDER, KEGG (Drug), DCDB, Expression Atlas, OMIM |
AUC, precision |
18 |
Clustering of Heterogeneous networks to repurpose the drugs [150]
|
Clustering |
NCBI Gene, KEGG Medicus |
– |
19 |
Use of Side effects in Network based approaches to drug repurposing [151]
|
Statistical analysis |
SIDER, FDA approved drugs |
– |